| |
| | New research on reduced bone mass and risk of fracture in postmenopausal women |
 | | However, there is little agreement on the level of bone reduction (i.e., the ideal T score) at which to begin treatment (including dietary and pharmacological interventions) to reduce the risk for fractures. |
 | | According to the National Osteoporosis Foundation (NOF), women with a T score of -2.0 or less or -1.5 or less with at least one risk factor should be treated to reduce the risk of fracture. |
 | | Ethel S. Siris, M.D., of Columbia-Presbyterian Medical Center, New York, and colleagues used data from 149,524 white postmenopausal women (average age, 64.5 years) enrolled in the National Osteoporosis Risk Assessment (NORA) study to examine the relationship between different treatment thresholds (based on T scores) and fracture incidence within a year of bone mineral density testing. |
| www.pharma-lexicon.com /medicalnews.php?newsid=8650 (1215 words) |
|